HUP1400025A1 - New dhydro-oxazinobenzodiazepine compounds a process for their preparation and pharmaceutical compositions containing them - Google Patents
New dhydro-oxazinobenzodiazepine compounds a process for their preparation and pharmaceutical compositions containing themInfo
- Publication number
- HUP1400025A1 HUP1400025A1 HUP1400025A HUP1400025A1 HU P1400025 A1 HUP1400025 A1 HU P1400025A1 HU P1400025 A HUP1400025 A HU P1400025A HU P1400025 A1 HUP1400025 A1 HU P1400025A1
- Authority
- HU
- Hungary
- Prior art keywords
- oxazinobenzodiazepine
- dhydro
- compounds
- preparation
- new
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
- C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
- C07D265/34—1,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings
- C07D265/36—1,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings condensed with one six-membered ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
- C07D498/14—Ortho-condensed systems
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Biomedical Technology (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Psychiatry (AREA)
- Psychology (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Priority Applications (9)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| HU1400025A HU230684B1 (en) | 2014-01-21 | 2014-01-21 | New dihydro-oxazinobenzodiazepine compounds, a process for their preparation and pharmaceutical compositions containing them |
| BR112016016892A BR112016016892A2 (pt) | 2014-01-21 | 2015-01-20 | Novos compostos de di-hidro-oxazinobenzodiazepina, um processo para sua preparação e composições farmacêuticas que os contêm |
| EA201691437A EA030371B1 (ru) | 2014-01-21 | 2015-01-20 | Дигидрооксазинобензодиазепиновые соединения, способ их получения и содержащие их фармацевтические композиции |
| JP2016547525A JP2017503817A (ja) | 2014-01-21 | 2015-01-20 | 新しいジヒドロ−オキサジノベンゾジアゼピン化合物、その製法及び前記化合物を含有する医薬組成物 |
| PCT/HU2015/000003 WO2015110848A1 (en) | 2014-01-21 | 2015-01-20 | New dihydro-oxazinobenzodiazepine compounds, a process for their preparation and pharmaceutical compositions containing them |
| CN201580010667.2A CN106211772A (zh) | 2014-01-21 | 2015-01-20 | 新的二氢‑噁嗪并苯并二氮*化合物、它们的制备方法以及含有它们的药物组合物 |
| CA2937300A CA2937300A1 (en) | 2014-01-21 | 2015-01-20 | New dihydro-oxazinobenzodiazepine compounds, a process for their preparation and pharmaceutical compositions containing them |
| US15/113,083 US9926332B2 (en) | 2014-01-21 | 2015-01-20 | Dihydro-oxazinobenzodiazepine compounds, a process for their preparation and pharmaceutical compositions containing them |
| EP15709984.7A EP3097110A1 (en) | 2014-01-21 | 2015-01-20 | New dihydro-oxazinobenzodiazepine compounds, a process for their preparation and pharmaceutical compositions containing them |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| HU1400025A HU230684B1 (en) | 2014-01-21 | 2014-01-21 | New dihydro-oxazinobenzodiazepine compounds, a process for their preparation and pharmaceutical compositions containing them |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| HUP1400025A1 true HUP1400025A1 (en) | 2015-07-28 |
| HU230684B1 HU230684B1 (en) | 2017-08-28 |
Family
ID=89991380
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HU1400025A HU230684B1 (en) | 2014-01-21 | 2014-01-21 | New dihydro-oxazinobenzodiazepine compounds, a process for their preparation and pharmaceutical compositions containing them |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US9926332B2 (hu) |
| EP (1) | EP3097110A1 (hu) |
| JP (1) | JP2017503817A (hu) |
| CN (1) | CN106211772A (hu) |
| BR (1) | BR112016016892A2 (hu) |
| CA (1) | CA2937300A1 (hu) |
| EA (1) | EA030371B1 (hu) |
| HU (1) | HU230684B1 (hu) |
| WO (1) | WO2015110848A1 (hu) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN112110811B (zh) * | 2019-06-20 | 2024-08-13 | 北京万全德众医药生物技术有限公司 | 一种比拉斯汀中间体的制备方法 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8419797D0 (en) | 1984-08-03 | 1984-09-05 | Beecham Group Plc | Compounds |
| ATE255112T1 (de) * | 1997-08-12 | 2003-12-15 | Egyt Gyogyszervegyeszeti Gyar | 1-3 dioxolo/4.5-h//2,3-benzodiazepin derivate als ampa/kainate-rezeptor-hemmer |
| UA67749C2 (uk) * | 1997-08-12 | 2004-07-15 | Егіш Дьйодьсердьяр Рт. | Похідна 8-заміщеного-9н-1,3-діоксол/4,5-h//2,3/бензодіазепіну з властивостями амра/каїнатного антагоніста, спосіб одержання похідних, фармацевтична композиція (варіанти), спосіб її одержання та спосіб лікування |
| HU230760B1 (hu) * | 2005-12-30 | 2018-03-28 | Egis Gyógyszergyár Nyilvánosan Működő Részvénytársaság | Dihidro-2,3-benzodiazepin-származékok optikai izomerjei, eljárás ezek sztereoszelektív szintézisére, alkalmazásuk, az ezeket tartalmazó gyógyszerkészítmények és az eljárás közbenső termékei |
| FR2972454B1 (fr) | 2011-03-08 | 2013-03-01 | Servier Lab | Nouveaux derives dihydro-oxazolobenzodiazepinones, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
-
2014
- 2014-01-21 HU HU1400025A patent/HU230684B1/hu unknown
-
2015
- 2015-01-20 CN CN201580010667.2A patent/CN106211772A/zh active Pending
- 2015-01-20 EA EA201691437A patent/EA030371B1/ru not_active IP Right Cessation
- 2015-01-20 JP JP2016547525A patent/JP2017503817A/ja not_active Withdrawn
- 2015-01-20 BR BR112016016892A patent/BR112016016892A2/pt not_active IP Right Cessation
- 2015-01-20 WO PCT/HU2015/000003 patent/WO2015110848A1/en active Application Filing
- 2015-01-20 US US15/113,083 patent/US9926332B2/en not_active Expired - Fee Related
- 2015-01-20 CA CA2937300A patent/CA2937300A1/en not_active Abandoned
- 2015-01-20 EP EP15709984.7A patent/EP3097110A1/en not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| US9926332B2 (en) | 2018-03-27 |
| WO2015110848A1 (en) | 2015-07-30 |
| US20170002020A1 (en) | 2017-01-05 |
| JP2017503817A (ja) | 2017-02-02 |
| HU230684B1 (en) | 2017-08-28 |
| EP3097110A1 (en) | 2016-11-30 |
| EA030371B1 (ru) | 2018-07-31 |
| BR112016016892A2 (pt) | 2022-08-30 |
| EA201691437A1 (ru) | 2017-02-28 |
| CA2937300A1 (en) | 2015-07-30 |
| CN106211772A (zh) | 2016-12-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1254657A1 (zh) | 新的羥基酯衍生物、其製備方法以及含有它們的藥物組合物 | |
| HK1254656A1 (zh) | 新的二環衍生物、其製備方法以及含有它們的藥物組合物 | |
| GB201409471D0 (en) | Pharmaceutical composition | |
| ZA201604976B (en) | Isoquinoline compounds, a process for their preparation, and pharmaceutical compositions containing them | |
| SG11201605366QA (en) | Pharmaceutical composition containing pyridylaminoacetic acidcompound | |
| GB201409488D0 (en) | Pharmaceutical composition | |
| GB201409485D0 (en) | Pharmaceutical composition | |
| RS59626B1 (sr) | Farmaceutska kompozicija koja sadrži mirabegron | |
| IL246619A0 (en) | A process for the recovery of a solid form of a pharmaceutical preparation | |
| ZA201700843B (en) | Oral pharmaceutical composition of isotretinoin | |
| ZA201502073B (en) | Pharmaceutical composition | |
| ZA201508726B (en) | Pharmaceutical composition | |
| PL3223799T3 (pl) | Sposób otrzymywania kompozycji składnik farmaceutyczny-polimer | |
| SG11201608123VA (en) | Pharmaceutical composition for external use | |
| HUE050881T2 (hu) | Gyógyszerkészítmény | |
| IL260425B (en) | New compounds of phosphinanes and azaphosphinanes, a process for their preparation and pharmaceutical compositions containing them | |
| HUP1400025A1 (en) | New dhydro-oxazinobenzodiazepine compounds a process for their preparation and pharmaceutical compositions containing them | |
| SG10201504332VA (en) | Pharmaceutical Composition | |
| SG11201608124XA (en) | Pharmaceutical composition for external use | |
| SG11201608122PA (en) | Pharmaceutical composition for external use |